May 27, 2020 Clinical Genomics Announces Publication of Additional Positive Data Reinforcing Key Benefits of COLVERA®, Blood Test for the Recurrence Monitoring of Colorectal Cancer in Cancer, an American Cancer Society Journal
Apr 30, 2020 Clinical Genomics Expands Strategic Relationship with Quest Diagnostics and Further Increases Momentum for Innovative First-Line Colorectal Cancer Screening Blood Test
Jun 24, 2019 MedicalResearch.com Colvera Blood Test Provides Improved Effectiveness Detecting Recurrence of Colorectal Cancer
Jun 13, 2019 Genomeweb Clinical Genomics Building Clinical Utility Evidence for Colorectal Cancer Recurrence Assay
Jan 3, 2019 Clinical Genomics Appoints Betsy Hanna CEO & Dr. Lawrence LaPointe Named Chief Innovation Officer
Nov 18, 2018 Clinical Genomics Partners with the Colorectal Cancer Alliance in the Life After Cancer Mission
Nov 1, 2018 Clinical Genomics and Quest Diagnostics Extend Collaboration to Provide InSure® ONE™, a Fecal Immunochemical Test for Colorectal Cancer Screening Programs
